Cure8 research brief
If AIEC contribute to Crohn’s disease for a given person, this study suggests host vitamin B12 levels and bacterial pdu pathway activity might influence bacterial invasion and inflammation — potentially pointing to new microbe–nutrient–targeted strategies.
Researchers studying microbiome–host interactions, clinicians and gastroenterologists interested in AIEC and Crohn’s disease mechanisms, and patients interested in emerging microbiome-targeted therapeutic ideas.
The researchers deleted pduB in a prototypical AIEC strain and found reduced invasion of intestinal epithelial cells and markedly less colitis in Il10-/- mice. They also observed higher host serum B12 after pduB loss, and showed that giving extra vitamin B12 inhibited AIEC invasion in vitro and protected Il10-/- mice from AIEC-driven colitis.
The suppression of invasion by B12 depended on an intact pdu pathway, linking a bacterial metabolic pathway to virulence.
The work is preclinical and done in bacterial strains and mouse models; it suggests that host vitamin B12 levels can influence AIEC pathogenicity and raises the idea that modifying microbe–nutrient interactions could be a therapeutic approach for AIEC-associated intestinal inflammation.
This is an abstract and preclinical (mouse and in vitro) study published in mBio. Findings in mice and bacterial strains do not directly translate to human clinical benefit; further work, including human studies, would be required before any change in clinical practice.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Researchers link a bacterial metabolic pathway (pdu/pduB) in AIEC to intestinal inflammation and show that host vitamin B12 availability can reduce bacterial invasion and colitis in mice—suggesting a modifiable host...
The work links climate and sociodemographic context to IBD burden in tropical regions, which can influence diagnostic recognition, resource needs, and research priorities for communities where IBD is rising.
This global survey shows that people with IBD prioritize symptom relief and psychological well-being over treatment features like administration route or speed of onset. That matters for shared decision-making, trial...
